nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa
|
Patrick, D.L |
|
2003 |
39 |
3 |
p. 335-345 11 p. |
artikel |
2 |
Does use of alternative medicine predict survival from cancer?
|
Risberg, T |
|
2003 |
39 |
3 |
p. 372-377 6 p. |
artikel |
3 |
Editorial Board
|
|
|
2003 |
39 |
3 |
p. ii- 1 p. |
artikel |
4 |
Erratum to “RhCG is downregulated in oesophageal squamous cell carcinomas, but expressed in multiple squamous epithelia”[European Journal of Cancer, 38 (2002) 1927–1936]
|
Chen, Bao-Sheng |
|
2003 |
39 |
3 |
p. 405- 1 p. |
artikel |
5 |
Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition
|
Welsh, S.J |
|
2003 |
39 |
3 |
p. 378-387 10 p. |
artikel |
6 |
Health effects of the Chernobyl accident: fears, rumours and the truth ☆ ☆ This review is based on a keynote lecture at the 24th Annual Meeting of the International Association of Cancer Registries held on 25–27 June 2002 in Tampere, Finland.
|
Rahu, Mati |
|
2003 |
39 |
3 |
p. 295-299 5 p. |
artikel |
7 |
High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer
|
Wils, J |
|
2003 |
39 |
3 |
p. 346-352 7 p. |
artikel |
8 |
Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences
|
von der Weid, N |
|
2003 |
39 |
3 |
p. 359-365 7 p. |
artikel |
9 |
Interferon-gamma upregulates MUC1 expression in haematopoietic and epithelial cancer cell lines, an effect associated with MUC1 mRNA induction
|
Reddy, P.K |
|
2003 |
39 |
3 |
p. 397-404 8 p. |
artikel |
10 |
Management of primary breast cancer in the elderly patient
|
Blamey, R.W |
|
2003 |
39 |
3 |
p. 286- 1 p. |
artikel |
11 |
News
|
|
|
2003 |
39 |
3 |
p. 269-273 5 p. |
artikel |
12 |
No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer families
|
Karppinen, S.-M. |
|
2003 |
39 |
3 |
p. 366-371 6 p. |
artikel |
13 |
Paediatric Update Announcement
|
|
|
2003 |
39 |
3 |
p. 358- 1 p. |
artikel |
14 |
Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer
|
Kerbrat, P |
|
2003 |
39 |
3 |
p. 317-320 4 p. |
artikel |
15 |
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer
|
Dittrich, C |
|
2003 |
39 |
3 |
p. 330-334 5 p. |
artikel |
16 |
Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma
|
Räty, R |
|
2003 |
39 |
3 |
p. 321-329 9 p. |
artikel |
17 |
Quality of life in patients with advanced colorectal cancer
|
Conroy, T |
|
2003 |
39 |
3 |
p. 287-294 8 p. |
artikel |
18 |
Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol
|
Vlems, F.A |
|
2003 |
39 |
3 |
p. 388-396 9 p. |
artikel |
19 |
The activity of raltitrexed (Tomudex®) in malignant pleural mesothelioma
|
Baas, P. |
|
2003 |
39 |
3 |
p. 353-357 5 p. |
artikel |
20 |
The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials
|
Bottomley, A. |
|
2003 |
39 |
3 |
p. 275-285 11 p. |
artikel |
21 |
This issue's topics
|
|
|
2003 |
39 |
3 |
p. ix-x nvt p. |
artikel |
22 |
Treatment of operable breast cancer in the elderly
|
Fentiman, I.S |
|
2003 |
39 |
3 |
p. 309-316 8 p. |
artikel |
23 |
Treatment of operable breast cancer in the elderly
|
Fentiman, I.S |
|
2003 |
39 |
3 |
p. 300-308 9 p. |
artikel |